CClinicalTrials.gg
CompletedNCT01770002Updated Apr 16, 2015

Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?

An interventional study of Everted suture technique and Non-everted suture technique in Basal Cell Carcinoma, Squamous Cell Carcinoma and Melanoma, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-04-16.

Sponsored by University of California, Davis · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators hypothesize that everting wound edges while suturing surgical sites will result in more aesthetic scars. Additionally, we also hypothesize that small to moderate wound irregularities present at 3 months will resolve by 6 months after surgery with no intervention

02

Conditions studied

  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma
  • Melanoma
03

In context

Carcinoma

6,741 studies on the registry are indexed under Carcinoma; 1,161 are open to participants now.

This study's enrollment of 50 is above the median of 45 across 5,170 interventional studies indexed under Carcinoma.

Browse Carcinoma studies →

Lead sponsor

University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.

Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Over 18 years of age
  • Able to give informed consent themselves
  • Willing to return for follow up visits

Exclusion criteria

Exclusion Criteria:

  • Mentally handicapped
  • Unable to understand written and oral English
  • Incarceration
  • Under 18 years of age
  • Unwilling to return for follow up
  • Pregnant Women
  • Wounds less than 3 cm in length
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Everted suture technique

    Technique that everts the skin; the edges will sit up against each other in a little peak, raised above the surrounding skin.

    Procedure: Everted suture technique

  • Active comparator
    Non-everted suture technique

    Surgical wound will be approximated such that the suture line is flat relative to the surrounding skin.

    Procedure: Non-everted suture technique

Interventions

  • ProcedureEverted suture technique
  • ProcedureNon-everted suture technique
06

What researchers measure

Primary outcomes

  1. Everted versus non-everted suturing techniques

    Primary outcome measures for this study are the post operative scar width measured at 1 cm from the midline on both sides of the scar.

    Time frame: 3 and 6 months

  2. Mean score of sum of 2 blinded observers POSAS scores

    The mean summed total of two blinded reviewers Physician Observer Scar Assessment Scale (POSAS) scores for each side of the wound.

    Time frame: 3 and 6 months

  3. Scar measurements (height, width, length)

    Scar volume will be measured in centimeters on both sides of the wound

    Time frame: 3 and 6 months

  4. Scar induration

    Scar induration area will be measured in centimeters for both sides of the wound

    Time frame: 3 and 6 months

  5. Scar erythema

    Scar erythema area will be measured in centimeters for both sides of the wound

    Time frame: 3 and 6 months

  6. Wound contour irregularities

    Wound contour irregularities will be measured in terms of volume in cubic centimeters via a length, width and height measurement

    Time frame: 3 and 6 months

  7. Stand cone volume

    The volume of standing cones will be measured via length, width and height measurements in centimeters

    Time frame: 3 and 6 months

  8. Uneven edge measurement

    The area of uneven edges will be measured via a length x height measurement in centimeters

    Time frame: 3 and 6 months

  9. Hyperpigmentation area

    areas of hyperpigmentation will be measured via a length x width measurement in centimeters

    Time frame: 3 and 6 months

Secondary outcomes

  1. Infection

    Infections occurring anytime during the study period will be recorded

    Time frame: up to 6 months

  2. wound dehiscence

    incidence of wound infection will be recorded anytime during the study period

    Time frame: up to 6 months

  3. spitting sutures

    spitting sutures will be counted for each side of the wound at 3 and 6 months

    Time frame: 3 and 6 months

07

Study locations

1 site
  • UC Davis, Department of Dermatology
    Sacramento, California 95816, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 16, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01770002
Lead sponsor
University of California, Davis
Responsible party
Sponsor
First posted
Jan 17, 2013
Start date
Jan 2012
Primary completion
Sep 2013
Completion
Sep 2014
Last update
Apr 16, 2015

Study contacts

Daniel Eisen, M.D.
principal investigator · University of California, Davis

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion